These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 54713)

  • 21. Nodular lymphocyte predominant Hodgkin lymphoma and diphenylhydantoin: report of a case and review of the literature.
    Sharma S; Menon H; Sengar M; Gujral S
    Indian J Pathol Microbiol; 2013; 56(4):440-2. PubMed ID: 24441243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Diphenylhydantoin and blood dyscrasias.
    Livingston S; Pauli LL
    JAMA; 1974 Oct; 230(2):211-2. PubMed ID: 4479170
    [No Abstract]   [Full Text] [Related]  

  • 23. [Multiple myeloma associated with phenytoin (diphenylhydantoin) therapy].
    Kanoh T; Dobashi H; Inada T
    Rinsho Ketsueki; 1996 Mar; 37(3):239-43. PubMed ID: 8727349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoproliferative disorders in four patients receiving chronic diphenylhydantoin therapy: etiologic correlation or chance association?
    Matzner Y; Polliack A
    Isr J Med Sci; 1978 Aug; 14(8):865-9. PubMed ID: 700999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter: Severe hypersensitivity to diphenylhydantoin with circulating antibodies to the drug.
    Kleckner HB; Yakulis V; Heller P
    Ann Intern Med; 1975 Oct; 83(4):522-3. PubMed ID: 1166986
    [No Abstract]   [Full Text] [Related]  

  • 26. Localized cutaneous pseudolymphoma associated with phenytoin therapy: a case report.
    Adams JD
    Australas J Dermatol; 1981 Apr; 22(1):28-9. PubMed ID: 7259668
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: Question on diphenylhydantoin dosage.
    Schwartz IL
    Pediatrics; 1975 Jun; 55(6):897. PubMed ID: 1134895
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lymphadenopathy in phenytoin treatment (author's transl)].
    Seyfeddinipur N
    Dtsch Med Wochenschr; 1976 Oct; 101(40):1454-6. PubMed ID: 823005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diphenylhydantoin-induced hepatitis: a case report.
    Gloria L; Serejo F; Cruz E; Freitas J; Costa A; Ramalho F; Batista A; de Moura MC
    Hepatogastroenterology; 1998; 45(20):411-4. PubMed ID: 9638415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diphenylhydantoin (phenytoin)--a potent psychopharmaceutic drug?].
    Lund K
    Tidsskr Nor Laegeforen; 1968 Nov; 88(22):2137-9. PubMed ID: 5725143
    [No Abstract]   [Full Text] [Related]  

  • 31. Is phenytoin carcinogenic?
    Lancet; 1971 Nov; 2(7733):1071-2. PubMed ID: 4106919
    [No Abstract]   [Full Text] [Related]  

  • 32. T lymphocytes mediate lymphadenopathy and autoimmunization in graft-versus host reactions and hypersensitivity to diphenylhydantoin.
    Gleichmann HI
    Agressologie; 1982 Jan; 23(A):53-5. PubMed ID: 6979267
    [No Abstract]   [Full Text] [Related]  

  • 33. Adult T-cell lymphoma following diphenylhydantoin therapy.
    Isobe T; Horimatsu T; Fujita T; Miyazaki K; Sugiyama T
    Nihon Ketsueki Gakkai Zasshi; 1980 Aug; 43(4):711-4. PubMed ID: 6784433
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenytoin (diphenylhydantoin).
    Med Lett Drugs Ther; 1976 Feb; 18(5):23-4. PubMed ID: 1256358
    [No Abstract]   [Full Text] [Related]  

  • 35. Phenytoin-induced pseudolymphoma with mycosis fungoides manifestations.
    Cooke LE; Hardin TC; Hendrickson DJ
    Clin Pharm; 1988 Feb; 7(2):153-7. PubMed ID: 3349752
    [No Abstract]   [Full Text] [Related]  

  • 36. Anticonvulsant-induced lymphoma.
    Fried MP; Sunwoo Y
    Laryngoscope; 1975 Oct; 85(10):1770-81. PubMed ID: 1186408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Control of long-term therapy with diphenylhydantoin. Gas-chromatographic determination of diphenylhydantoin and hydroxy-diphenylhydantoin].
    Mascher J; Bernhardt W
    Z Neurol; 1973 May; 204(3):179-92. PubMed ID: 4123516
    [No Abstract]   [Full Text] [Related]  

  • 38. Diphenylhydantoin-induced hepatic necrosis. A case study.
    Lee TJ; Carney CN; Lapis JL; Higgins T; Fallon HJ
    Gastroenterology; 1976 Mar; 70(3):422-4. PubMed ID: 814030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.
    Reynolds EH
    Proc R Soc Med; 1975 Feb; 68(2):102-4. PubMed ID: 1166035
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case of diphenylhydantoin induced lymphadenopathy (author's transl)].
    Ashizawa T; Oda E; Sakuragawa N; Shibata A; Sekiya M; Nemoto K; Okamura A; Ohnishi Y
    Rinsho Ketsueki; 1979 Apr; 20(4):393-9. PubMed ID: 449058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.